Mark Flather | Vice President of Investor Relations |
Shawn Singh | Chief Executive Officer |
Jerrold Dotson | Chief Financial Officer |
Andrew Tsai | Jefferies LLC |
Timothy Lugo | William Blair & Company LLC |
Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.